Traders Sell CVS Health (CVS) on Strength (CVS)
Traders sold shares of CVS Health Corp (NYSE:CVS) on strength during trading on Tuesday. $93.37 million flowed into the stock on the tick-up and $138.21 million flowed out of the stock on the tick-down, for a money net flow of $44.84 million out of the stock. Of all companies tracked, CVS Health had the 31st highest net out-flow for the day. CVS Health traded up $0.51 for the day and closed at $78.61
CVS has been the topic of a number of recent research reports. Mizuho set a $95.00 target price on CVS Health and gave the company a “buy” rating in a report on Wednesday, June 13th. Royal Bank of Canada dropped their target price on CVS Health to $84.00 and set an “outperform” rating on the stock in a report on Friday, June 29th. Morgan Stanley decreased their price target on CVS Health from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 3rd. Citigroup restated a “buy” rating and issued a $81.00 price target on shares of CVS Health in a research note on Monday, July 9th. Finally, Leerink Swann set a $80.00 price target on CVS Health and gave the company an “outperform” rating in a research note on Thursday, August 9th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $86.85.
The company has a quick ratio of 1.87, a current ratio of 2.34 and a debt-to-equity ratio of 1.73. The company has a market cap of $78.30 billion, a price-to-earnings ratio of 13.21, a P/E/G ratio of 1.03 and a beta of 1.00.
In related news, EVP Kevin Hourican sold 8,564 shares of the company’s stock in a transaction on Monday, August 27th. The stock was sold at an average price of $75.00, for a total value of $642,300.00. Following the completion of the transaction, the executive vice president now directly owns 12,135 shares in the company, valued at $910,125. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.53% of the stock is owned by corporate insiders.
A number of institutional investors have recently added to or reduced their stakes in CVS. Ashburton Jersey Ltd increased its stake in CVS Health by 2.9% during the second quarter. Ashburton Jersey Ltd now owns 60,597 shares of the pharmacy operator’s stock worth $3,899,000 after acquiring an additional 1,711 shares during the last quarter. LFA Lugano Financial Advisors SA acquired a new stake in CVS Health during the second quarter worth about $176,000. Chicago Partners Investment Group LLC increased its stake in CVS Health by 9.8% during the second quarter. Chicago Partners Investment Group LLC now owns 12,292 shares of the pharmacy operator’s stock worth $791,000 after acquiring an additional 1,094 shares during the last quarter. Truvestments Capital LLC acquired a new stake in CVS Health during the second quarter worth about $1,474,000. Finally, WealthTrust Fairport LLC increased its stake in CVS Health by 29,115.8% during the second quarter. WealthTrust Fairport LLC now owns 5,551 shares of the pharmacy operator’s stock worth $357,000 after acquiring an additional 5,532 shares during the last quarter. Hedge funds and other institutional investors own 82.71% of the company’s stock.
CVS Health Company Profile (NYSE:CVS)
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
See Also: What is the NASDAQ Stock Market?
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.